Boehringer Ingelheim Corporation Release: Large Scale Registry Shows Atrial Fibrillation Management is Suboptimal and Unequal Around the World

MUNICH--(BUSINESS WIRE)-- New one-year follow-up results from the global RE-LY AF registry, a multinational primary care registry, have been announced for the first time during the European Society of Cardiology (ESC) Congress 2012. The findings show that 11.7% of patients with atrial fibrillation (AF) who were included in the registry from January 2008 to April 2011 had died within one year.1 The registry mainly reflects data from patients before novel oral anticoagulants became available.